HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arunkumar Arumugam Selected Research

Glioma (Gliomas)

1/2015Receptor activator for nuclear factor-κB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arunkumar Arumugam Research Topics

Disease

15Breast Neoplasms (Breast Cancer)
01/2019 - 01/2011
11Neoplasms (Cancer)
03/2021 - 06/2012
8Neoplasm Metastasis (Metastasis)
03/2021 - 01/2014
5Pancreatic Neoplasms (Pancreatic Cancer)
02/2017 - 01/2014
3Carcinogenesis
10/2015 - 01/2014
2Genomic Instability
12/2016 - 01/2015
1Triple Negative Breast Neoplasms
03/2021
1COVID-19
09/2020
1Glioma (Gliomas)
01/2015
1Inflammation (Inflammations)
01/2015
1Adenocarcinoma
10/2014
1Bone Fractures (Bone Fracture)
07/2014
1Bone Resorption
07/2014
1Osteoporosis
07/2014
1Hyperglycemia
01/2013
1B-Cell Lymphoma (Lymphoma, B Cell)
07/2012

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
02/2017 - 06/2012
5Hormones (Hormone)IBA
01/2015 - 01/2011
3MicroRNAs (MicroRNA)IBA
10/2015 - 08/2014
3ProgesteroneFDA LinkGeneric
01/2015 - 01/2011
3Estradiol (Delestrogen)FDA LinkGeneric
01/2014 - 01/2011
2nimbolideIBA
03/2021 - 01/2016
2Somatotropin Receptors (Growth Hormone Receptor)IBA
01/2019 - 10/2014
2Biomarkers (Surrogate Marker)IBA
12/2016 - 10/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
05/2016 - 01/2016
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2015 - 07/2012
2Estrogens (Estrogen)FDA Link
01/2015 - 01/2014
2SteroidsIBA
07/2014 - 01/2011
2CarcinogensIBA
01/2014 - 06/2012
2Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
01/2014 - 06/2012
2Caspase 3 (Caspase-3)IBA
07/2012 - 06/2012
1RNA (Ribonucleic Acid)IBA
09/2020
1Estrogen ReceptorsIBA
01/2019
1Adenosine Triphosphate (ATP)IBA
01/2019
1Docetaxel (Taxotere)FDA Link
01/2019
1geduninIBA
02/2017
1Antineoplastic Agents (Antineoplastics)IBA
02/2017
1Caveolin 1IBA
12/2016
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
12/2016
1PaxillinIBA
12/2016
1Blood Proteins (Serum Proteins)IBA
12/2016
1EnzymesIBA
05/2016
1AntioxidantsIBA
05/2016
1Superoxide DismutaseIBA
05/2016
1SaltsIBA
01/2016
13-methyladenineIBA
01/2016
1chloroquine diphosphateFDA LinkGeneric
01/2016
1benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
01/2016
1OSM-LIF ReceptorsIBA
07/2015
1Apoptosis Regulatory ProteinsIBA
01/2015
1MAP-kinase-activated kinase 2IBA
01/2015
1LigandsIBA
01/2015
1Mifepristone (RU 486)FDA Link
01/2015
1NF-kappa B (NF-kB)IBA
01/2015
1Aurora KinasesIBA
01/2015
1Aromatase (CYP19)IBA
07/2014
1Aromatase InhibitorsIBA
07/2014
1Histones (Histone)IBA
02/2014
1matrigelIBA
01/2014
1Growth Factor ReceptorsIBA
01/2014
1Small Interfering RNA (siRNA)IBA
01/2014
1AgarIBA
01/2014
1Insulin-Like PeptidesIBA
01/2014
1LeptinIBA
01/2013
1Cyclin D1IBA
07/2012
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
07/2012
1CathepsinsIBA
07/2012
1Messenger RNA (mRNA)IBA
06/2012
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
06/2012

Therapy/Procedure

1Therapeutics
10/2015
1Drug Therapy (Chemotherapy)
01/2015
1Radiotherapy
01/2015
1Withholding Treatment
01/2014
1Complementary Therapies (Alternative Medicine)
01/2014